Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis.
Fujinaga Y, Kawaratani H, Kaya D, Tsuji Y, Ozutsumi T, Furukawa M, Kitagawa K, Sato S, Nishimura N, Sawada Y, Takaya H, Kaji K, Shimozato N, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H.
Fujinaga Y, et al. Among authors: yoshiji h.
Int J Mol Sci. 2020 Aug 4;21(15):5589. doi: 10.3390/ijms21155589.
Int J Mol Sci. 2020.
PMID: 32759852
Free PMC article.